AEYE Health's AI Eye Screening Solution Expands Integration With Epic Across U.S.

AEYE Health Enhances Epic Integration for AI Eye Screening

AEYE Health, a frontrunner in retinal diagnostics, has made significant strides by expanding its integration with Epic, one of the leading electronic medical record (EMR) systems in the United States. This integration aims to revolutionize the landscape of diabetic eye screening through the use of AEYE-DS, a state-of-the-art AI solution designed for quick and efficient diabetic retinopathy examinations.

Streamlined Real-Time Results

In a groundbreaking advancement, healthcare providers can now order diabetic eye exams directly from Epic. Results are provided in real time, allowing for screenings in under one minute without disrupting clinical workflows. This brings a new level of efficiency to primary care, endocrinology, and diabetes care centers, particularly in addressing the needs of patients with diabetes.

The process is straightforward: a nurse or medical assistant captures a single retinal image using a portable camera linked to AEYE-DS, and results are instantly integrated into the patient's medical record. If any signs of diabetic retinopathy are detected, an automated alert is sent to the ophthalmology department for timely follow-up. By minimizing the time between ordering and receiving results, AEYE Health is effectively closing significant care gaps experienced by these patients.

Coping with Care Gaps

Diabetic retinopathy (DR) is a leading cause of vision loss in diabetic patients, and traditional screening methods often create barriers to timely detection and management. With this enhanced integration, AEYE Health is addressing these critical concerns, particularly as screenings under the new process align with the Healthcare Effectiveness Data and Information Set (HEDIS) measures and can be fully reimbursed under CPT code 92229, which represents the first AI-specific reimbursement code in the U.S.

This initiative reflects AEYE Health's commitment to improving health outcomes through technology, ensuring more diabetics receive the essential eye care they need.

A Focus on Automation

Zack Dvey-Aharon, Ph.D., Co-Founder and CEO of AEYE Health, emphasized the importance of this integration, stating, "This enhanced integration makes diabetic retinopathy screening in Epic faster and more seamless than ever. With an exam completed in under one minute and everything being automated, healthcare providers can focus on what is really important and deliver fast and accurate AI retinal screening right at the point of care."

The broader implication of such technology adoption is the rapid scaling of AEYE-DS across hospitals and clinics, which not only enhances diagnostic accuracy but also promotes a proactive approach to managing diabetic eye health. This is crucial considering the growing number of individuals diagnosed with diabetes in the U.S., where effective and timely screening can prevent lasting damage and preserve sight.

Expanding Access to Diagnostic Solutions

AEYE Health isn’t stopping here; the company has already supported multiple major EMR platforms and plans to continue expanding its reach. By broadening access to AI retinal screening, the company is determined to make eye care more practical, accurate, and accessible for all patients.

In summary, AEYE Health’s integration with Epic is a significant advancement in the world of healthcare technology, particularly for diabetic patients who often face barriers to receiving timely eye care. With the combination of AI and accessible platforms like Epic, the future of diagnostic screenings looks promising, paving the way for improved patient outcomes and enhanced healthcare experiences.

About AEYE Health

AEYE Health has distinguished itself as a digital health company committed to delivering fully autonomous, AI-based diagnostic screening solutions for retinal imaging. With a focus on usability and clinical performance, the company aims to ensure that diabetic retinopathy screenings are accessible, accurate, and efficient, particularly for underserved patient populations across the United States.